Equity and Noncontrolling Interest

12 Months Ended

Dec. 31, 2020

Equity [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

Note 23 – Equity and Accumulated Other Comprehensive Loss

The Company has

30,000,000

 shares of common stock authorized with a par value of $

1

, and

17,850,616

 and

17,735,162

 shares

issued and outstanding as of December 31, 2020 and 2019, respectively. The change in shares issued and outstanding during 2020

was primarily related to

49,906

 shares issued for share-based compensation plans and

65,548

 shares issued for the exercise of stock

options and other share activity. 

The Company is authorized to issue

10,000,000

 shares of preferred stock with $

1

 par value, subject to approval by the Board of

Directors. The Board of Directors may designate one or more series of preferred stock and the number of shares, rights, preferences,

and limitations of each series. As of December 31, 2020, no preferred stock had been issued.

The Company has a share repurchase program that was approved by its Board of Directors in 2015 for the repurchase of up to

$

100.0

 million of Quaker Chemical Corporation common stock. The Company has not repurchased any shares under the program for

the years ended December 31, 2020, 2019 and 2018. As of December 31, 2020, there was approximately $

86.9

 million of common

stock remaining to be purchased under this share repurchase program.

The following table shows the reclassifications from and resulting balances of AOCI for the years ended December 31, 2020,

2019 and 2018:

Defined

Unrealized

Gain (Loss) in

Currency

Benefit

Translation

Pension

Available-for -

Derivative

Adjustments

Plans

Sale Securities

Instruments

Total

Balance as of December 31, 2017

$

(31,893)

$

(34,093)

$

886

$

—

$

(65,100)

Other comprehensive (loss) income before

 reclassifications

(17,429)

1,543

(2,622)

—

(18,508)

Amounts reclassified from AOCI

—

3,085

435

—

3,520

Related tax amounts

—

(1,086)

459

—

(627)

Balance as of December 31, 2018

(49,322)

(30,551)

(842)

—

(80,715)

Other comprehensive income (loss) before

 reclassifications

4,754

(8,088)

2,951

(415)

(798)

Amounts reclassified from AOCI

—

3,169

(301)

—

2,868

Related tax amounts

—

937

(557)

95

475

Balance as of December 31, 2019

(44,568)

(34,533)

1,251

(320)

(78,170)

Other comprehensive income (loss) before

 reclassifications

41,693

(6,617)

2,848

(4,257)

33,667

Amounts reclassified from AOCI

—

24,141

(202)

—

23,939

Related tax amounts

—

(6,458)

(555)

979

(6,034)

Balance as of December 31, 2020

$

(2,875)

$

(23,467)

$

3,342

$

(3,598)

$

(26,598)

All reclassifications related to unrealized gain (loss) in available-for-sale securities relate to the Company’s equity interest in a

captive insurance company and are recorded in equity in net income of associated companies. The amounts reported in other

comprehensive income for non-controlling interest are related to currency translation adjustments.